Tempus AI (NASDAQ:TEM) Stock Price Up 2% - Should You Buy?

Shares of Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) rose 2% during mid-day trading on Tuesday . The company traded as high as $78.67 and last traded at $69.74. Approximately 17,873,241 shares were traded during mid-day trading, an increase of 48% from the average daily volume of 12,048,808 shares. The stock had previously closed at $68.36.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on TEM. Loop Capital cut their price objective on Tempus AI from $57.00 to $52.00 and set a "buy" rating for the company in a research report on Tuesday, January 14th. Wolfe Research began coverage on shares of Tempus AI in a report on Friday, December 13th. They set an "outperform" rating and a $60.00 price objective on the stock. Stifel Nicolaus lowered shares of Tempus AI from a "buy" rating to a "hold" rating and upped their price target for the company from $45.00 to $65.00 in a report on Monday, November 11th. Guggenheim began coverage on shares of Tempus AI in a research note on Monday, December 9th. They set a "buy" rating and a $74.00 target price on the stock. Finally, Needham & Company LLC reiterated a "buy" rating and issued a $56.00 price objective on shares of Tempus AI in a report on Tuesday, January 14th. Four equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat.com, Tempus AI has a consensus rating of "Moderate Buy" and a consensus target price of $58.55.

Tempus AI Stock Performance

The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The stock's fifty day moving average is $46.60 and its two-hundred day moving average is $50.32.

Insider Activity

In other Tempus AI news, major shareholder Bradley A. Keywell sold 395,800 shares of Tempus AI stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $42.95, for a total transaction of $16,999,610.00. Following the sale, the insider now owns 16,164,449 shares in the company, valued at $694,263,084.55. The trade was a 2.39 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director David R. Epstein sold 620 shares of the company's stock in a transaction dated Wednesday, December 11th. The stock was sold at an average price of $41.81, for a total transaction of $25,922.20. Following the transaction, the director now owns 27,894 shares in the company, valued at approximately $1,166,248.14. This trade represents a 2.17 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 2,401,779 shares of company stock worth $115,707,361.

Institutional Trading of Tempus AI

Hedge funds have recently modified their holdings of the company. ARK Investment Management LLC increased its stake in Tempus AI by 132.1% during the 4th quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company's stock worth $186,343,000 after purchasing an additional 3,141,487 shares in the last quarter. NEA Management Company LLC lifted its holdings in Tempus AI by 17.8% during the 3rd quarter. NEA Management Company LLC now owns 5,385,979 shares of the company's stock valued at $304,846,000 after purchasing an additional 813,169 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. lifted its holdings in Tempus AI by 166.0% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company's stock valued at $109,352,000 after purchasing an additional 2,021,394 shares during the last quarter. Nikko Asset Management Americas Inc. lifted its holdings in shares of Tempus AI by 166.0% during the fourth quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company's stock worth $109,352,000 after buying an additional 2,021,394 shares in the last quarter. Finally, Franklin Resources Inc. increased its position in shares of Tempus AI by 240.5% in the fourth quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company's stock worth $93,251,000 after purchasing an additional 1,950,862 shares during the period. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.